Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Revelation Biosciences Inc (NASDAQ: REVB) was $0.61 for the day, down -4.88% from the previous closing price of $0.64. In other words, the price has decreased by -$4.88 from its previous closing price. On the day, 0.89 million shares were traded. REVB stock price reached its highest trading level at $0.67 during the session, while it also had its lowest trading level at $0.55.
Ratios:
Our analysis of REVB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REVB now has a Market Capitalization of 5111671 and an Enterprise Value of -3915357.
Stock Price History:
Over the past 52 weeks, REVB has reached a high of $25.26, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -4.37%, while the 200-Day Moving Average is calculated to be -55.54%.
Shares Statistics:
REVB traded an average of 3.05M shares per day over the past three months and 13009270 shares per day over the past ten days. A total of 8.36M shares are outstanding, with a floating share count of 8.35M. Insiders hold about 0.07% of the company’s shares, while institutions hold 5.67% stake in the company. Shares short for REVB as of 1734048000 were 43682 with a Short Ratio of 0.01, compared to 1731628800 on 428599. Therefore, it implies a Short% of Shares Outstanding of 43682 and a Short% of Float of 0.52.
